Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05194293
Title Regorafenib and Durvalumab for the Treatment of High-Risk Liver Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Academic and Community Cancer Research United
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Cancer Center RECRUITING Birmingham Alabama 35233 United States Details
University of Florida Health Science Center - Gainesville WITHDRAWN Gainesville Florida 32610 United States Details
Emory University Hospital/Winship Cancer Institute NOT_YET_RECRUITING Atlanta Georgia 30322 United States Details
Carle Cancer Center NCI Community Oncology Research Program WITHDRAWN Urbana Illinois 61801 United States Details
Medical College of Wisconsin RECRUITING Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field